ITCMDBv1
Clinical TrialID 2433

Endodontic Medications for Irreversible Pulpitis: Articaine or Eugenol?

NCT03472456

Pulpitides|Endodontic Inflammation|Toothaches|Operative Dentistry

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
2433
Evidence Id
2433
Core Evidence Id
2433
Source Clinical Trial Id
2410
Herb2 Clinical Trial Id
HBCT002410
Nct Id
NCT03472456
Title
Endodontic Medications for Irreversible Pulpitis: Articaine or Eugenol?
Status
Completed
Phase
Study Result
No
Study Condition
Pulpitides|Endodontic Inflammation|Toothaches|Operative Dentistry
Study Type
Observational
Study Design
Observational Model: |Time Perspective: p
Intervention
DRUG: Implementation of a pulp medication in compliance with the dental emergency management protocol: articaïne|DRUG: Implementation of a pulp medication in compliance with the dental emergency management protocol: eugenol
Intervention Allocation
Intervention Model
Intervention Mask
Intervention Purpose
Gender
All
Age
Adult, Older_Adult
Enrollment
100
Outcome Measure
Pain evolution (decrease or increase the intensity of the pain), Evolution of pain (using a score of 0 to 10), 7 days
Sponsor Collaborator
University Hospital, Strasbourg, France
Funded By
OTHER
Location
Les Hôpitaux Universitaires de Strasbourg, Strasbourg, 67091, France
Other Id
6953
Start Date
2018-03-22
Primary Completion Date
2018-03-22
Completion Date
2019-10-24
First Posted
2018-03-21
Results First Posted
Last Update Posted
2020-09-17
Study Document
Study Url
https://clinicaltrials.gov/study/NCT03472456
Title Cn
Title En
Endodontic Medications for Irreversible Pulpitis: Articaine or Eugenol?
Bilingual Status
semi_complete